Thanks to our unique antibody production technology, antigens can be set with high flexibility! We will introduce examples of monoclonal antibody production in our article.
This article introduces examples of monoclonal antibody production. The antibody craftsman's monoclonal antibody production service utilizes a unique antibody production technology that does not rely on animals, allowing for a high degree of flexibility in setting antigens. This enables the production of antibodies that can recognize slight differences in antigens or have specific binding sites tailored to the purpose, resulting in antibodies with special specificities that meet specific needs. HuCAL technology has over 10 years of proven results worldwide, having produced 14,000 antibodies. Its success rate over the past three years boasts over 90%, and it is adopted by many pharmaceutical companies and others. [Contents] ■ Examples of monoclonal antibody production (with work overview) ■ Other antibody production examples *Detailed content of the article can be viewed via the related links. *For detailed specifications, please refer to the PDF materials or feel free to contact us.
Inquire About This Product
basic information
【Other Published Content (Excerpt)】 ■Examples of Monoclonal Antibody Production (with Work Overview) - Antibodies that bind to homologous regions - Antibodies that distinguish phosphorylated modifications - Antibodies that distinguish the last few amino acids *For detailed content of the article, please refer to the related links. *For detailed specifications, please refer to the PDF materials or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
*You can view the detailed content of the article through the related link. *For detailed specifications, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Gene Frontier has been expanding its business areas that contribute to the acceleration of biopharmaceuticals, including antibody drugs, and has been advancing the development of its unique technologies. Moving forward, we aim to accelerate our research and development and business development to achieve further growth on a global scale. We will continue to provide unique technologies and services for the development of innovative pharmaceuticals and diagnostic drugs, striving to be a trusted partner for our customers and contribute to 21st-century healthcare.